Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.

Rehfeld, Jens F et al.·Scandinavian journal of gastroenterology·2018·
RPEP-038632018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
Published In:
Scandinavian journal of gastroenterology, 53(12), 1429-1432 (2018)
Database ID:
RPEP-03863

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-03863·https://rethinkpeptides.com/research/RPEP-03863

APA

Rehfeld, Jens F; Knop, Filip K; Asmar, Ali; Madsbad, Sten; Holst, Jens J; Asmar, Meena. (2018). Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.. Scandinavian journal of gastroenterology, 53(12), 1429-1432. https://doi.org/10.1080/00365521.2018.1530297

MLA

Rehfeld, Jens F, et al. "Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.." Scandinavian journal of gastroenterology, 2018. https://doi.org/10.1080/00365521.2018.1530297

RethinkPeptides

RethinkPeptides Research Database. "Cholecystokinin secretion is suppressed by glucagon-like pep..." RPEP-03863. Retrieved from https://rethinkpeptides.com/research/rehfeld-2018-cholecystokinin-secretion-is-suppressed

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.